Reporting
These studies are finished enrolling participants and collecting data, and are now working on analyzing the data and sharing results.
-
CTNPT 039: The I-Score/Opal Implementation Pilot Study
Electronic capture through the Opal patient portal of a patient-reported measure of barriers to antiretroviral therapy adherence: a mixed method type 3 hybrid pilot study at a large Montreal HIV clinic
-
CTNPT 035: Vitamin D insufficiency and NAFLD in persons living with HIV
Association of vitamin D insufficiency with non-alcoholic fatty liver disease in HIV mono-infected patients
-
CTNPT 011: Monitoring penicillin levels for syphilis
Penicillin therapeutic drug monitoring in the treatment of infectious syphilis. Do low serum penicillin concentrations correlate with treatment failure?
-
CTNPT 015: COMO cognition study with HIV+ patients
Pilot project to implement a step-wise investigation that includes Cerebrospinal Fluid analysis as a standard of care for HIV+ individuals with cognitive symptoms
-
CTN 265: The sexual confidence study
HIV prevention for gay and bisexual men via reduction of social anxiety and substance use in sexual situations
-
CTN 262: Canadian HIV women’s sexual and reproductive health cohort study (CHIWOS)
Canadian HIV women’s sexual and reproductive health cohort study
-
CTN 254: Inflammation as a predictor of HIV disease progression
Predictive value of inflammatory biomarkers in untreated HIV disease progression, and their response to initiation of antiretroviral therapy
-
CTN 248: Incentives to Stop AIDS and HIV in Drug Users
A randomized clinical trial evaluating the role of contingent reinforcement in the engagement and retention of Drug Users in HAART programs: a substudy of CTN 244
-
CTN 247: Canadian cohort of HIV+ slow progressors
A study of host and viral factors associated with disease progression in long term HIV infected subjects
-
CTN 253: H1N1 flu vaccine study in HIV-positive adults
PCIRN evaluation of pandemic H1N1 (2009) influenza vaccine in adults with human immunodeficiency virus infection
-
CTN 233: Pharmacokinetics of antiretroviral therapy (ARV) in HIV-positive women
Predictors of antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy
-
CTNPT 002: SPOT Impact of counselling on sexual risk behaviours
SPOT, a rapid HIV testing intervention for MSM: measuring the impact of counselling on sexual risk behaviours
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.v
Learn More